Gualberto Ruaño, M.D., Ph.D., President and Chief Executive Officer. Dr. Ruaño has been an entrepreneur in the biotechnology industry for 20 years, and is a pioneer in the technology and business of personalized medicine. Previously, he founded Genaissance Pharmaceuticals in 1997 as the pioneer company in pharmacogenomics, and served as CEO and as Chief Scientific Officer. As CEO, he raised $60 million of private equity, led the company's $90 million IPO in 2000, and negotiated R&D partnerships with major pharmaceutical and biotechnology companies. As CSO of Genaissance, Dr. Ruaño developed fundamental technology for genetic associations based on gene haplotypes. Prior to that, as co-founder of BIOS Laboratories since 1992, he invented the Coupled Amplification and Sequencing System (U.S. patent 5,427,911) for the rapid determination of sequence variation, which is marketed worldwide by Siemens Healthcare Diagnostics as TRUGENE™ and was the first pharmacogenomic diagnostic system approved by the FDA. Dr. Ruaño is a founding Director of the Personalized Medicine Coalition in Washington, D.C. and is senior editor of the journal Personalized Medicine (London). He has served on steering committees working with the FDA on pharmacogenomic guidelines and as a member at the Manhattan Institute's 21st Century FDA Task Force. Dr. Ruaño also serves on advisory committees of the National Academy of Clinical Biochemistry instituting guidelines for pharmacogenetic testing in the clinical laboratory. He has an M.D. and PhD. from Yale University and a B.A. from Johns Hopkins University (Phi Beta Kappa). Dr. Ruaño is also Director of Genetics Research at Hartford Hospital and holds Adjunct Professorships on the medical faculties at George Washington University and the University of Puerto Rico. He is a Fellow of the National Academy of Clinical Biochemistry and of the American Institute for medical and Biological Engineering.
Mohan Kocherla, M.S, MS-MIS., Technical Operations Director. Mr. Kocherla has over 10 years of experience in Biotechnology, Laboratory Operations, Genomics and Information Technology. At Genomas, Mr. Kocherla has designed state of the art high throughput research and clinical laboratories that now process thousands of patient samples to support the company's PhysioGenomics Laboratory and Laboratory of Personalized Health. Prior to working at Genomas, Mr. Kocherla served as Good Laboratory Practice (GLP) Coordinator in the Department of Tropical Medicine at The George Washington University in Washington D.C. Mr. Kocherla holds a Bachelor of Science degree in Microbiology and Chemistry from Osmania University, India; Advanced Diploma in Network Centered Computing from National Institute of Information Technology, India; Master of Science in Management Information Systems from Ferris State University, Michigan; and Master of Science in Genomics and Bioinformatics from The George Washington University, D.C. He is presently pursuing Master of Business Administration degree from University of Hartford with a concentration in Management and Finance. Mr. Kocherla also holds certificates of training in Good Laboratory Practices, Good Manufacturing Practices for operation of advanced Optical Scanners and Bio-Robots.
Teresa Giuliano, Sales Director. Mrs. Giuliano has 25 years of extensive experience in pharmaceutical sales. Most recently a neuroscience specialty sales representative for Innovex, Inc. (Morrisville, NC), she had responsibility for promotion of Zyprexa® and Strattera® to psychiatrists in Connecticut. Prior to that, Mrs. Giuliano served as a District manager for Diopsys, Inc (Pinebrook, NJ) with responsibility for the introduction of a new vision medical device technology in New England. Priorly, she held sales positions of increasing responsibility with Serono, Inc, (Rockland, MA) as Key Account Manager for neurology drugs and Bristol-Myers Squibb (New York, NY) as Institutional Neuroscience Specialist. She holds a BS degree in Marketing from the University of Connecticut.
Theodore Holford, Ph.D., Senior Biostatistical Consultant. Dr. Holford is Susan Dwight Bliss Professor of Public Health (Biostatistics), Professor of Statistics and Head of the Division of Biostatistics at Yale University School of Medicine. The fields in which he has collaborated and used his methods include cancer epidemiology, perinatal epidemiology, environmental health sciences, spinal cord injury studies, psychiatry, geriatrics and pediatrics. He is one of the founding editors of Statistical Methods in Medical Research. In addition, he is the author of Multivariate Methods in Epidemiology (Oxford University Press 2002), a textbook and standard reference on statistical methods in epidemiological research. In addition, he has made significant methodological contributions to multivariate analysis of matched studies, log-linear models for survival, analysis of time trends for disease, and population models for disease trends.